Thanks to the positive safety signals and promising trends in clinical efficacy in this Phase 1b/2a trial, the development program for Oncostellae in UC is continuing in development as a gut-restricted JAK inhibitor approach
Semaglutide GLP-1 , a medication approved to treat type 2 diabetes, functions by imitating the GLP-1 hormone, which regulates blood sugar levels
Investigations could include: The causative drug is stopped, where possible
Focus shifts toward consistent habits rather than intensive restriction: regular meal patterns, mindful eating practices, ongoing physical activity, and self-monitoring (such as weekly weighing)
INFORMATION MOUNJARO (tirzepatide) 10mg/0.6ml KwikPen is a onceweekly, singleneedle subcutaneous injection supplied as a singlepatientuse pen that delivers four fixed 10mg doses for adults with type 2 diabetes who have already titrated through lower strengths and need additional glycaemic and weight loss support
Donnelly RF, Garland MJ, Morrow DIJ, Migalska K, Singh TRR, Majithiya R, Woolfson AD